Identifying mechanisms that support nanoparticle therapy for autoimmune diseases

Identifying mechanisms that support nanoparticle therapy for autoimmune diseases

Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the antigen-specific tolerance inducing abilities of a novel nanoparticle therapy for treating autoimmune diseases, according to a recent study published in Science Advances.